Loop Drainage: Effectiveness in Treating Cutaneous Abscesses

December 15, 2021 updated by: Richard Gentry Wilkerson, University of Maryland, Baltimore

Evaluation of Loop Drainage Technique Versus Standard Incision and Drainage for Treatment of Simple Soft Tissue Abscesses

In the Emergency Department (ED), patients frequently seek medical treatment for cutaneous abscesses. Traditional incision and drainage (I&D), with or without packing of cutaneous abscesses has long been the accepted standard of care. This procedure is often very painful for the patient. Additionally, compliance with wound care and follow-up can present barriers to proper care and healing. Research has suggested that incision and loop drainage of an abscess may be another effective treatment for simple cutaneous abscess. Thus far, research into this procedure has been limited to the pediatric population with small sample sizes. In these previous studies, this technique was found to be an effective and less painful treatment for abscesses. Research has not been done in the adult population using this procedure. If this procedure is found to be as effective and less painful in the adult population, then it should be considered as a potential preferred I&D method for cutaneous abscess in the ED.

Study Overview

Detailed Description

Patients who meet study criteria for treatment of a simple cutaneous abscess and desire to be a part of this study, will be consented. Study subjects will be enrolled and randomly assigned to either the study or control groups.

Control Group- standard I & D method for cutaneous abscess.

Study Group- Loop Technique:

  1. Gather all of your material and bring to bedside
  2. Clean area with chlorhexidine or iodine swabs
  3. Anesthetize area
  4. Use your scalpel to make small 5mm incision at most fluctuant area of abscess
  5. Explore cavity with your hemostat and break down loculations
  6. Make second incision less than 4cm away from first incision. Feel borders of abscess, and try to make second incision as far within cavity as you can.
  7. For larger abscesses can repeat step 5 thus creating several LOOPs.
  8. Irrigate cavity with saline flush
  9. Pass hemostat through both incisions and pull loop vessel, penrose, or bottom of glove through. Keep your loop device equal in length on both sides.
  10. Tie loop device loosely over 30cc syringe to form LOOP. Usually 5-6 knots. This helps prevent loop from falling out prematurely.
  11. Slide syringe out, and trim free ends of loop. Make sure loop is mobile.
  12. Cover site with dry dressing. Follow-Up-

    • Wound check in 1-2 days
    • Patient may manage drain at home by rotating it to facilitate drainage and prevent adhesion
    • Patient will be instructed to return to the Emergency Department for drain removal in 5-7 days.

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21201
        • University of Maryland Medical Systems

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. 18 years or older
  2. Presents to ED with simple cutaneous abscess
  3. Provides informed consent.

Exclusion Criteria:

  1. Under 18 years of age
  2. Abscess too small for performance of procedure
  3. Signs of systemic infection
  4. Need for hospitalization
  5. Previously treated for current abscess
  6. Clinician determines abscess would not be amenable to drainage by loop technique
  7. Patients known to be pregnant
  8. Incarcerated patients
  9. Students / Employees of the facility
  10. Presence of any other condition(s) that the investigator feels makes the patient unsuitable for study inclusion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Traditional Incision and Drainage
Treatment of a simple cutaneous abscess with traditional incision and drainage with or without packing, decision made at the discretion of the provider.
Control Group- Standard treatment of a simple cutaneous abscess with traditional I&D technique with or without packing utilizing a standard I&D kit.
Experimental: Loop drainage
Treatment of a simple cutaneous abscess with incision and drainage using the loop drainage technique.
Study Group- Treatment of a simple cutaneous abscess with the loop drainage technique utilizing an standard I&D kit and the cuff of a sterile glove for a loop device.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Procedure failure rate
Time Frame: 5 -7 days after procedure
Determining the difference in failure rates between the study group and control group. Treatment failure is a composite outcome defined as having the presence of any of the following: requiring a 2nd incision and drainage procedure, a patient that requires administration of antibiotics after the initial treatment period due to worsening clinical status, a patient that requires hospitalization after the initial treatment period due to worsening clinical status.
5 -7 days after procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in pain associated with the procedure using a visual analog pain scale
Time Frame: Measured after the procedure on day 1
To evaluate the difference in pain between the experimental and control groups associated with the procedure using a visual analog pain scale (0-100).
Measured after the procedure on day 1
Patient Satisfaction using a visual analog pain scale
Time Frame: 5-7 days after procedure
To measure the difference in patient satisfaction with overall treatment between the study and control groups using the visual analog scale (0-100).
5-7 days after procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: R. Gentry Wilkerson, MD, U of Maryland, Baltimore

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2016

Primary Completion (Actual)

February 1, 2018

Study Completion (Actual)

February 1, 2018

Study Registration Dates

First Submitted

February 4, 2016

First Submitted That Met QC Criteria

March 2, 2016

First Posted (Estimate)

March 3, 2016

Study Record Updates

Last Update Posted (Actual)

January 5, 2022

Last Update Submitted That Met QC Criteria

December 15, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HP-00066974

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abscess of Skin and/or Subcutaneous Tissue

Clinical Trials on Traditional Incision and Drainage.

3
Subscribe